Ads
related to: treatment of fuchs corneal dystrophy and cataract loss disease problems- Payment Calculator
Detailed financing estimates.
Calculate your payment & prequalify
- Apply Online Now
See if you prequalify in minutes.
Accepted at over 260,000 locations!
- Testimonials & Reviews
Hear what our cardholders say
Real stories from real people
- Average Hearing Costs
Healthcare costs are rising.
CareCredit helps now more than ever
- Are You A Provider?
Learn the benefits of CareCredit®.
We help people get care they need
- About CareCredit®
What we do at CareCredit is simple.
We help people get care they need
- Payment Calculator
smartholidayshopping.com has been visited by 1M+ users in the past month
Search results
Results From The WOW.Com Content Network
Fuchs heterochromic iridocyclitis (FHI) is a chronic unilateral uveitis appearing with the triad of heterochromia, predisposition to cataract and glaucoma, and keratitic precipitates on the posterior corneal surface. Patients are often asymptomatic and the disease is often discovered through investigation of the cause of the heterochromia or ...
Fuchs dystrophy, also referred to as Fuchs endothelial corneal dystrophy (FECD) and Fuchs endothelial dystrophy (FED), is a slowly progressing corneal dystrophy that usually affects both eyes and is slightly more common in women than in men. Although early signs of Fuchs dystrophy are sometimes seen in people in their 30s and 40s, the disease ...
Keratoconus, a progressive, noninflammatory, bilateral, asymmetric disease, characterized by paraxial stromal thinning and weakening that leads to corneal surface distortion. [2] Keratoglobus, a rare noninflammatory corneal thinning disorder, characterised by generalised thinning and globular protrusion of the cornea. [3]
When affected by some reason, such as Fuchs' dystrophy or a trauma during cataract removal, endothelial cells suffer mortality or damage. [1] The corneal endothelial cells normally do not undergo mitotic cell division, and cell loss results in permanent loss of function.
It is typically characterized by a clear, bilateral thinning in the inferior and peripheral region of the cornea, although some cases affect only one eye. The cause of the disease remains unclear. Pellucid marginal degeneration is diagnosed by corneal topography. Corneal pachymetry may be useful in confirming the diagnosis.
An intracameral injection is usually of an antibiotic into the anterior chamber of the eyeball to prevent endophthalmitis caused by an infection of the eye that can occur after cataract surgery. The Food and Drug Administration (FDA) has not approved antibiotics for this use and it is considered 'off-label'.
Ad
related to: treatment of fuchs corneal dystrophy and cataract loss disease problems